WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for the full-year 2026, while maintaining annual revenue growth outlook.
For fiscal 2026, the company now projects adjusted earnings in a range of $12.62 to $12.72 per share, up from the prior forecast range of $12.52 to $12.72 per share.
The company continues to expect revenue growth in the low single-digit plus, with constant currency revenue growth in the low single-digit.
In Wednesday's pre-market trading, BDX is trading on the NYSE at $172.00, up $1.34 or 0.79 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
